Causes and effects of the chronic inflammation in venous leg ulcers

Acta Dermato-Venereologica, Supplement

Volumn , Issue 210, 2000, Pages 3-17

  Agren, M S ^a   Eaglstein, W H ^a   Ferguson, M W J ^a   Harding, K G ^a   Moore, K ^a   Saarialho Kere, U K ^a   Schultz, G S ^a  

^a NONE   (Denmark)

Author keywords

Compression therapy; Cytokines; Etiology; Fibroblasts; Fibronectin; Growth factors; Immunohistochemistry; In situ hybridization; Integrins; Matrix metalloproteinases; Neutrophil elastase; Tissue inhibitors of metalloproteinases; Venous insufficiency; Wound fluid; Wound healing

Indexed keywords

ALPHA 2 MACROGLOBULIN; BETA1 INTEGRIN; COLLAGEN; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3B RECEPTOR; CYTOKINE; DNA; EPIDERMAL GROWTH FACTOR; FIBRINOGEN; FIBRONECTIN; GROWTH FACTOR; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LAMININ; LEUKOCYTE ELASTASE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN P55; PROTEINASE; TENASCIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; GROWTH PROMOTOR; PROTEINASE INHIBITOR;

CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DISEASE SEVERITY; FIBROBLAST; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LEG COMPRESSION; LEG ULCER; MICROCIRCULATION; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VENOUS PRESSURE; WOUND HEALING; CHRONIC DISEASE; INFLAMMATION; LEG; LONGITUDINAL STUDY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; VARICOSIS; VASCULARIZATION; VEIN INSUFFICIENCY;

CHRONIC DISEASE; CYTOKINES; ENDOPEPTIDASES; FIBROBLASTS; GROWTH SUBSTANCES; HUMANS; INFLAMMATION; LEG; LONGITUDINAL STUDIES; PROTEASE INHIBITORS; VARICOSE ULCER; VENOUS INSUFFICIENCY;

EID: 0033821949     PISSN: 03658341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (150)

1. Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers
2. Histologic evaluation of chronic human wounds treated with hydrocolloid and non-hydrocolloid dressings
3. Socioeconomic impact of chronic venous insufficiency and leg ulcers
4. Chronic ulceration of the leg: Extent of the problem and the provision of care
5. Leg ulcers: Epidemiology and aetiology
6. Studies on leg and foot ulcers
7. Epidemiology of chronic venous ulcers
8. Venous and non-venous leg ulcers: Clinical history and appearance in a population study
9. Long-term prognosis for patients with chronic venous leg ulcers: A prospective cohort study
10. Cost effectiveness of community leg ulcer clinics: Randomised controlled trial
11. Single-visit venous ulcer assessment clinic: The first year
12. Does venous reflux matter?
13. Early benefits of subfacial endoscopic perforator surgery (SEPS) in healing venous ulcers
14. Venous insufficiency and perforating veins
15. Venous leg ulcers: A prognostic index to predict time to healing
16. Venous ulcer healing by four-layer compression bandaging is not influenced by the pattern of venous incompetence
17. Localization of dermal edema in lipodermatosclerosis, lymphedema, and cardiac insufficiency. High-frequency ultrasound examination of intradermal echogenicity
18. The peripheral resistance in arteries of legs is inversely proportional to the severity of chronic venous insufficiency
19. The veno-arteriolar reflex in venous leg ulcer patients studied by laser Doppler imaging
20. Changes in calf muscle function in chronic venous disease
21. Pathophysiology of venous leg ulceration - An update
22. Causes of venous ulceration: A new hypothesis
23. White cell accumulation in dependent legs of patients with venous hypertension: A possible mechanism for trophic changes in the skin
24. Expression of elastase and fibrin in venous leg ulcer biopsies: A pilot study of pentoxifylline versus placebo
25. Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: Implications for venous ulcer formation
26. Dermal pericapillary fibrin in venous disease and venous ulceration
27. Inappropriate neutrophil activation in venous disease
28. Overload of iron in the skin of patients with varicose ulcers
29. The potential intermediate role of lysosomes in oxygen free radical production
30. Human neutrophil and mast cell proteases implicated in inflammation
31. The cause of venous ulceration
32. Pericapillary fibrin in the ulcer-bearing skin of the leg: The cause of lipodermatosclerosis and venous ulceration
33. Tissue oxygenation, venous ulcers and fibrin cuffs
34. 2 diffusion block?
35. Wound fluid from venous leg ulcers degrades plasminogen and reduces plasmin generation by keratinocytes
36. The occurrence of pericapillary fibrin in venous hypertension and ischaemic leg ulcers: A histopathological study
37. Pericapillary fibrin cuffs in venous ulceration. Persistence with treatment and during ulcer healing
38. Pericapillary fibrin cuffs in venous disease. A reappraisal
39. Capillary underperfusion in chronic venous insufficiency: A cause for leg ulceration?
40. The 'trap' hypothesis of venous ulceration
41. Venous ulceration
42. A rejected letter to the editors of The Lancet and the need for angiologists to prove their usefulness
43. Leg ulcer. Conservative management or surgical treatment?
44. Sustained compression and healing of chronic venous ulcers
45. Venous ulceration
46. A systematic review of compression treatment for venous leg ulcers
47. Microcirculatory disturbances - The final cause for venous leg ulcers?
48. Skin compression increases capillary blood velocity in patients with chronic venous disease
49. Controlled trial of occlusive dressings in healing chronic venous ulcers
50. The influence of dressings on venous ulcer healing - A randomised trial
51. The use of short-stretch bandaging to control oedema
52. Two therapeutic models are compared: Better results with optimized compression
53. Randomised trial of two grades of compression stockings in the prevention of venous ulcer recurrence - 5 Year outcomes
54. Cell biology of chronic wounds: The role of inflammation
55. Human wound contraction: Collagen organization, fibroblasts, and myofibroblasts
56. Human wound repair. II. Inflammatory cells, epithelial-mesenchymal interactions, and fibrogenesis
57. Comparison of the effects of moist and dry conditions on dermal repair
58. New method for assessing epidermal wound healing: The effect of triamcinolone acetonide and polyethelene film occlusion
59. Topical tretinoin and epithelial wound healing
60. Detection of undegraded fibrin and tumor necrosis factor-α in venous leg ulcers
61. Immunohistochemical characterization of the cutaneous cellular infiltrate in different areas of chronic leg ulcers
62. T lymphocytes and the lack of activated macrophages in wound margin biopsies from chronic leg ulcers
63. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds
64. IL-10 and GM-CSF expression and the presence of antigen-presenting cells in chronic venous ulcers
65. The role of the macrophage in wound repair. A study with hydrocortisone and anti-macrophage serum
66. Promotion of wound repair in old mice by local injection of macrophages
67. Lymphocyte function in wound healing and following injury
68. Extravasation of macromolecules and possible trapping of transforming growth factor-β in venous ulceration
69. Clinical histochemical and immunohistochemical investigation of the capillary basal membrane in chronic venous insufficiency
70. Pericapillary fibrin cuff: A histological sign of venous leg ulceration
71. Increased expression of platelet-derived growth factor receptor alpha and beta and vascular endothelial growth factor in the skin of patients with chronic venous insufficiency
72. Immunohistochemical investigation of dermal capillaries in chronic venous insufficiency
73. Expression of the adhesion molecules ICAM-1, VCAM-1, E-selectin and their ligands VLA-4 and LFA-1 in chronic venous leg ulcers
74. Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency
75. Histological study of white blood cells and their association with lipodermatosclerosis and venous ulceration
76. Growth factors and wound healing: Part II. Role in normal and chronic wound healing
77. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth
78. Inhibition of cell proliferation by chronic wound fluid
79. Effect of chronic wound fluid on fibroblasts
80. Effects of chronic wound fluid on the bioactivity of platelet-derived growth factor in serum-free medium and its direct effect on fibroblast growth
81. Proliferation of dermal fibroblasts induced by wound fluid from chronic venous leg ulcers is dependent on healing status and age of fibroblast donor
82. Growth factors and chronic wounds: The need to understand the microenvironment
83. Studies on cytokines related to wound healing in donor site wound fluid
84. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds
85. Biochemical analysis of acute and chronic wound environments
86. Healing rate and bacterial necrotizing vasculitis in venous leg ulcers
87. Cytokine and protease levels in healing and non-healing chronic venous leg ulcers
88. Levels of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in chronic venous leg ulcers - Correlations to healing status
89. Protease inhibitors protect growth factor activity in chronic wounds
90. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors
91. Up-regulation of elastase in acute wounds of healthy aged humans and chronic venous leg ulcers are associated with matrix degradation
92. Effects of chronic wound fluid on the structure and biological activity of becaplermin (rhPDGF-BB) and becaplermin gel
93. A human tissue explant culture system for the study of wound biology
94. Cytokine secretion by explant cultures of human chronic wound tissue
95. Chemokine and inflammatory cytokine changes during chronic wound healing
96. Workshop on the pathogenesis of chronic wounds
97. Epidermal proliferation is not impaired in chronic venous ulcers
98. Ulcer bed infection. Report of a case of enlarging venous leg ulcer colonized by Pseudomonas aeruginosa
99. The fibroblast and wound repair
100. The wound environment as a regulator of fibroblast phenotype
101. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds
102. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from venous leg ulcers is ulcer-age-dependent
103. The serial cultivation of human diploid cell strains
104. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group
105. Risk factors associated with the failure of a venous leg ulcer to heal
106. Longitudinal study of in vivo wound repair and in vitro cellular senescence of dermal fibroblasts
107. Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors
108. Fibroblasts cultured from venous ulcers display cellular characteristics of senescence
109. The effect of passage number on fibroblast cellular senescence in patients with chronic venous insufficiency with and without ulcer
110. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers
111. Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB
112. Fibroblast senescence in pressure ulcers
113. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation
114. Wound healing - Aiming for perfect skin regeneration
115. Impaired wound healing in mice with a disrupted plasminogen gene
116. Augmented inflammatory responses and altered wound healing in cathepsin G-deficient mice
117. Impaired wound contraction in stromelysin-1-deficient mice
118. Matrix metalloproteinases (MMPs) are required for re-epithelialization of cutaneous wounds
119. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization
120. Venous ulcer fibroblasts compared with normal fibroblasts show differences in collagen but not fibronectin production under both normal and hypoxic conditions
121. Fibronectin profiles in normal and chronic wound fluid
122. Degradation of fibronectin and vitronectin in chronic wound fluid: Analysis by cell blotting, immunoblotting, and cell adhesion assays
123. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, α1-proteinase inhibitor, and α2-macroglobulin
124. Syndecans, heparan proteoglycans, maintain the proteolytic balance of acute wounds
125. Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers
126. Alpha-1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: The inhibitor protects fibronectin from degradation by chronic wound fluid enzymes
127. Tenascin-C degradation in chronic wounds is dependent of serine proteinase activity
128. Matrix metalloproteinases
129. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds
130. Matrix metalloproteinase 9 level predicts optimal collagen deposition during early wound repair in humans
131. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers
132. Collagenase in wound healing: Effect of wound age and type
133. Gelatinase activity during wound healing
134. Proteolytic remodeling of extracellular matrix
135. Matrix metalloproteinases in skin
136. Chronic inflammation modulates the expression of epithelial adhesion proteins and integrins at the basement membrane zone
137. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases a (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers
138. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations
139. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA
140. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans
141. Protease levels in fluids collected chronic venous/arterial leg ulcers before and during healing
142. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers
143. Persistent elevation of MMP-9 in chronic venous leg ulcers
144. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds
145. Collagenase expression is rapidly induced in wound-edge keratinocytes after acute injury in human skin, persists during healing, and stops at re-epithelialization
146. Epidermal expression of collagenase delays wound-healing in transgenic mice
147. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds
148. Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds
149. Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers
150. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing